[go: up one dir, main page]

Kanje et al., 1989 - Google Patents

Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve

Kanje et al., 1989

Document ID
11337620164121165149
Author
Kanje M
Skottner A
Sjo J
et al.
Publication year
Publication venue
Brain research

External Links

Snippet

The effect of insulin-like growth factor I (IGF-I) was tested on regeneration of the rat sciatic nerve after a crush lesion. IGF-I was administered via miniosmotic pumps to the dorsal root ganglia or locally around the crus lesion. Regeneration of sensory fibers was measured after …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations

Similar Documents

Publication Publication Date Title
Kanje et al. Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve
Laird et al. Acidic fibroblast growth factor stimulates motor and sensory axon regeneration after sciatic nerve crush in the rat
DE69924615T2 (en) THYMOSINE BETA 4 STIMULATED WOUND HEALING
EP0308386B1 (en) New medical use
Konturek et al. Effects of epidermal growth factor on gastrointestinal secretions
US6174857B1 (en) Composition and method for the treatment of osteoporosis in mammals
US6083912A (en) Method for soft tissue augmentation
Kanje et al. Effects of growth hormone treatment on the regeneration of rat sciatic nerve
Baird et al. Immunoreactive fibroblast growth factor (FGF) in a transplantable chondrosarcoma: inhibition of tumor growth by antibodies to FGF
Stone et al. Neuropeptide Y and the ocular innervation of rat, guinea pig, cat and monkey
TURINSKY Glucose and amino acid uptake by exercising muscles in vivo: effect of insulin, fiber population, and denervation
Tornqvist et al. Substance P-immunoreactive nerve fibres in the anterior segment of the rabbit eye: Distribution and possible physiological significance
Mizisin et al. NT-3 attenuates functional and structural disorders in sensory nerves of galactose-fed rats
US5567682A (en) Method of treating Alzheimer's disease
WO1992022311A1 (en) New medicinal use of igf-ii
Tache et al. Stimulation of gastric secretion by acute lateral hypothalamic lesions and its reversal by intracisternal injection of bombesin
Vaccarino et al. Centrally administered hypothalamic growth hormone-releasing factor stimulates food intake in free-feeding rats
US6143714A (en) Methods of using hepatocyte growth factor to promote survival, growth and differentiation of motor neurons
US5990080A (en) Use of protein S-100-b in medicines containing the protein S-100b
Hanesch Neuropeptides in dural fine sensory nerve endings—involvement in neurogenic inflammation?
Gutkowska et al. Effect of morphine on urine output: possible role of atrial natriuretic factor
CA2549863A1 (en) Use of relaxin as adjuvant in the differentiation of stem cells for the reconstruction of tissues
Avrith et al. Renin-like effects of NGF evaluated using renin-angiotensin antagonists
AOKI et al. Involvement of vasoactive intestinal peptide (VIP) as a humoral mediator of penile erectile function in the dog
Accili et al. Presence and actions of vasoactive intestinal peptide in the isolated rabbit heart